Item request has been placed!
×
Item request cannot be made.
×
Processing Request
29P Characterization of T cell responses induced by the individualized mRNA neoantigen vaccine autogene cevumeran in adjuvant stage II (high risk)/stage III colorectal cancer (CRC) patients (pts) from the biomarker cohort of the phase II BNT122-01 trial.
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
- Author(s): Elez Fernandez, M.E.1 (AUTHOR); Maurel, J.2 (AUTHOR); Morris, V.3 (AUTHOR); Kopetz, S.4 (AUTHOR); Galligan, B.5 (AUTHOR); Ali, S.6 (AUTHOR); Derhovanessian, E.7 (AUTHOR); Unsal-Kacmaz, K.8 (AUTHOR); Manning, L.9 (AUTHOR); Henn, H.9 (AUTHOR); Weisenburger, T.10 (AUTHOR); Tonigold, M.11 (AUTHOR); Zurek, P.12 (AUTHOR); Fierek-Ulbig, M.13 (AUTHOR); Cortini, A.12 (AUTHOR); Pino Claveria, M.13 (AUTHOR); Preussner, L.14 (AUTHOR); Mueller, F.15 (AUTHOR); Türeci, Ö.16 (AUTHOR); Sahin, U.16 (AUTHOR)
- Source:
Annals of Oncology. 2024 Supplement 1, Vol. 35, pS14-S15. 2p.
- Subject Terms:
No Comments.